Organogenesis Holdings, Inc. (ORGO)
0.8101
-0.15
(-16.05%)
USD |
NASDAQ |
Nov 13, 16:00
0.8354
+0.03
(+3.12%)
After-Hours: 06:38
Organogenesis Holdings Total Liabilities (Quarterly) : 106.16M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 106.16M |
| June 30, 2026 | 118.31M |
| March 31, 2026 | 138.64M |
| December 31, 2025 | 164.81M |
| September 30, 2025 | 123.85M |
| June 30, 2025 | 99.91M |
| March 31, 2025 | 99.32M |
| December 31, 2024 | 112.57M |
| September 30, 2024 | 167.75M |
| June 30, 2024 | 179.66M |
| March 31, 2024 | 180.45M |
| December 31, 2023 | 181.36M |
| September 30, 2023 | 185.78M |
| June 30, 2023 | 179.03M |
| March 31, 2023 | 182.41M |
| December 31, 2022 | 183.69M |
| September 30, 2022 | 200.94M |
| June 30, 2022 | 201.97M |
| March 31, 2022 | 193.04M |
| December 31, 2021 | 201.92M |
| September 30, 2021 | 181.25M |
| Date | Value |
|---|---|
| June 30, 2021 | 176.64M |
| March 31, 2021 | 161.89M |
| December 31, 2020 | 148.41M |
| September 30, 2020 | 180.95M |
| June 30, 2020 | 180.74M |
| March 31, 2020 | 168.04M |
| December 31, 2019 | 165.10M |
| September 30, 2019 | 161.83M |
| June 30, 2019 | 144.88M |
| March 31, 2019 | 143.89M |
| December 31, 2018 | 116.64M |
| September 30, 2018 | 13.14M |
| June 30, 2018 | 16.75M |
| March 31, 2018 | 15.91M |
| December 31, 2017 | 14.78M |
| September 30, 2017 | 13.55M |
| June 30, 2017 | 10.94M |
| March 31, 2017 | 10.99M |
| December 31, 2016 | 11.33M |
| September 30, 2016 | 0.8526M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| cbdMD, Inc. | 4.934M |
| Guardian Pharmacy Services, Inc. | 212.06M |
| Lineage Cell Therapeutics, Inc. | 34.17M |
| Tenax Therapeutics, Inc. | 8.355M |
| Heron Therapeutics, Inc. | 225.53M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 368.90M |
| Shareholders Equity (Quarterly) | 262.74M |
| Debt to Equity Ratio | 0.2456 |
| Current Ratio | 3.319 |
| Net Debt Paydown Yield | -2.67% |